The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Antipsychotic Metabolic Effects: Weight Gain, Diabetes Mellitus, and Lipid Abnormalities
Open accessAbstract
Objective: To review published and nonpublished literature describing changes in weight, glucose homeostasis, and lipid milieu with antipsychotics. Methods: A Medline search was completed using the words weight gain, diabetes mellitus, cholesterol, triglycerides, risperidone, clozapine, olanzapine, quetiapine, ziprasidone, predictors, prolactin, obesity, and conventional antipsychotics. Publications, including original articles, review articles, letters to the editor, abstracts or posters presented at professional meetings in the last 4 years, and references from published articles, were collected. Manufacturers, including Eli Lilly Canada Inc, Janssen-Ortho Inc, Pfizer Canada Inc, AstraZeneca Inc, and Novartis Pharmaceuticals, were contacted to retrieve additional medical information. Results: The topic of antipsychotic-induced weight gain is understudied, and there are relatively few well-controlled studies. Weight gain as a side effect has been described with both conventional and atypical antipsychotics. Moreover, some atypical antipsychotics are associated with de novo diabetes mellitus and increased serum triglyceride levels. Predictors of weight gain may be age, baseline body mass index, appetite stimulation, previous antipsychotic exposure, and antipsychotic treatment duration. Conclusion: Significant weight gain is reported with the existing atypical antipsychotics. The weight gain described is highly distressing to patients, may reduce treatment adherence, and may increase the relative risk for diabetes mellitus and hypertriglyceridemia. Physicians employing these agents should routinely monitor weight, fasting blood glucose, and lipid profiles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., & Burn, P. (1995) · Science · doi:10.1126/science.7624778 · Cited by 3,243
Congenital leptin deficiency is associated with severe early-onset obesity in humans
Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., et al. (1997) · Nature · doi:10.1038/43185 · Cited by 2,936
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
The Spread of the Obesity Epidemic in the United States, 1991-1998
Mokdad, A. H. (1999) · JAMA · doi:10.1001/jama.282.16.1519 · Cited by 2,280
Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency
Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., Hughes, I. A., McCamish, M. A., & O'Rahilly, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411204 · Cited by 1,998
Body Weight and Mortality among Women
Manson, J. E., Willett, W. C., Stampfer, M. J., Colditz, G. A., Hunter, D. J., Hankinson, S. E., Hennekens, C. H., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509143331101 · Cited by 1,988
Heymsfield, S. B., Greenberg, A. S., Fujioka, K., Dixon, R. M., Kushner, R., Hunt, T., Lubina, J. A., Patane, J., Self, B., Hunt, P., et al. (1999) · JAMA · doi:10.1001/jama.282.16.1568 · Cited by 1,422
Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors
Tecott, L. H., Sun, L. M., Akana, S. F., Strack, A. M., Lowenstein, D. H., Dallman, M. F., & Julius, D. (1995) · Nature · doi:10.1038/374542a0 · Cited by 1,274
Effects of gender, body composition, and menopause on plasma concentrations of leptin.
Rosenbaum, M., Nicolson, M., Hirsch, J., Heymsfield, S. B., Gallagher, D., Chu, F., & Leibel, R. L. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784109 · Cited by 810
Tran, P. V., Hamilton, S. H., Kuntz, A. J., Potvin, J. H., Andersen, S. W., Beasley, C. J., & Tollefson, G. D. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199710000-00010 · Cited by 715
Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study
Henderson, D. C., Cagliero, E., Gray, C., Nasrallah, R. A., Hayden, D. L., Schoenfeld, D. A., & Goff, D. C. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.975 · Cited by 701
Polycystic Ovaries and Hyperandrogenism in Women Taking Valproate for Epilepsy
Isojarvi, J., Laatikainen, T. J., Pakarinen, A. J., Juntunen, K., & Myllyla, V. V. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311043291904 · Cited by 688
Metabolic fuels and reproduction in female mammals
Wade, G. N., & Schneider, J. E. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80183-6 · Cited by 686
Prevalence of Attempting Weight Loss and Strategies for Controlling Weight
Serdula, M. K. (1999) · JAMA · doi:10.1001/jama.282.14.1353 · Cited by 523
Novel antipsychotics: comparison of weight gain liabilities.
Wirshing, D. A., Wirshing, W. C., Kysar, L., Berisford, M. A., Goldstein, D., Pashdag, J., Mintz, J., & Marder, S. R. (1999) · PubMed · Cited by 523
Novel antipsychotics and new onset diabetes
Wirshing, D. A., Spellberg, B. J., Erhart, S. M., Marder, S. R., & Wirshing, W. C. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00100-0 · Cited by 407
Novel Antipsychotics: Comparison of Weight Gain Liabilities
Wirshing, D. A., Wirshing, W. C., Kysar, L., Berisford, M. A., Goldstein, D., Pashdag, J., Mintz, J., & Marder, S. R. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0602 · Cited by 393
The Distribution of Body Mass Index Among Individuals With and Without Schizophrenia
Allison, D. B., Fontaine, K. R., Heo, M., Mentore, J. L., Cappelleri, J. C., Chandler, L. P., Weiden, P. J., & Cheskin, L. J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0402 · Cited by 390
Topiramate: Preclinical Evaluation of a Structurally Novel Anticonvulsant
Shank, R. P., Gardocki, J. F., Vaught, J. L., Davis, C. B., Schupsky, J. J., Raffa, R. B., Dodgson, S. J., Nortey, S. O., & Maryanoff, B. E. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02459.x · Cited by 345
Clozapine-induced weight gain: prevalence and clinical relevance
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.1.68 · Cited by 248
Olanzapine Increases Weight and Serum Triglyceride Levels
Osser, D. N., Najarian, D. M., & Dufresne, R. L. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1109 · Cited by 229
Hebebrand, J., Blum, W. F., Barth, N., Coners, H., Englaro, P., Juul, A., Ziegler, A., Warnke, A., Rascher, W., & Remschmidt, H. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000282 · Cited by 228
Body Weight and Leptin Plasma Levels During Treatment With Antipsychotic Drugs
Kraus, T., Haack, M., Schuld, A., Hinze-Selch, D., K�hn, M., Uhr, M., & Pollm�cher, T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.312 · Cited by 221
New-Onset Diabetes Mellitus and Diabetic Ketoacidosis Associated With Olanzapine Treatment
Goldstein, L. E., Sporn, J., Brown, S., Kim, H., Finkelstein, J., Gaffey, G. K., Sachs, G., & Stern, T. A. (1999) · Psychosomatics · doi:10.1016/s0033-3182(99)71210-7 · Cited by 220
Bymaster, F. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00146-7 · Cited by 200
Pharmacologic activation of limbic structures and neuroimaging studies of emotions.
Beasley, C. M., Tollefson, G. D., & Tran, P. V. (1997) · PubMed · Cited by 197
Use of topiramate, a new anti-epileptic as a mood stabilizer
Marcotte, D. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00110-4 · Cited by 197
Clozapine and Associated Diabetes Mellitus
Popli, A. P., Konicki, P. E., Jurjus, G. J., Fuller, M. A., & Jaskiw, G. E. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0304 · Cited by 185
Umbricht, D., Pollack, S. Z., & Kane, J. (1994) · PubMed · Cited by 179
Smoking and therapeutic response to clozapine in patients with schizophrenia
McEvoy, J. P., Freudenreich, O., & Wilson, W. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00377-1 · Cited by 172
Olanzapine-Induced Ketoacidosis With Diabetes Mellitus
LINDENMAYER, J., & PATEL, R. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1471 · Cited by 169
Serum leptin levels increase rapidly after initiation of clozapine therapy
Brömel, T., Blum, W. F., Ziegler, A., Schulz, E., Bender, M., Fleischhaker, C., Remschmidt, H., Krieg, J.-C., & Hebebrand, J. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000352 · Cited by 167
Neuroleptic-induced hyperprolactinemia
Dickson, R. A., & Glazer, W. M. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00159-5 · Cited by 161
Differential effect of clozapine on weight: a controlled study
Bustillo, J., Buchanan, R. W., Irish, D., & Breier, A. F. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.6.817 · Cited by 157
Topiramate as add‐on treatment for patients with bipolar mania
Chengappa, K. R., Rathore, D., Levine, J., Atzert, R., Solai, L. K., Parepally, H., Levin, H., Moffa, N., Delaney, J., & Brar, J. S. (1999) · Bipolar Disorders · doi:10.1034/j.1399-5618.1999.10111.x · Cited by 155
Baptista, T., Parada, M. A., & Hernandez, L. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90340-6 · Cited by 131
Weight Gain Associated With Neuroleptic Medication: A Review
Stanton, J. M. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.3.463 · Cited by 130
Weight gain associated with antipsychotic drugs.
Ganguli, R. (1999) · PubMed · Cited by 123
New-Onset Diabetes Mellitus Associated With the Initiation of Quetiapine Treatment
Sobel, M., Jaggers, E. D., & Franz, M. A. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0809f · Cited by 122
Weight Gain: Side Effect of Atypical Neuroleptics?
Wetterling, T., & MuBigbrodt, H. E. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199908000-00006 · Cited by 121
Mood Stabilization and Weight Loss With Topiramate
Gordon, A., & Price, L. H. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.968a · Cited by 119
Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics
Frye, M. A., Ketter, T. A., Altshuler, L. L., Denicoff, K., Dunn, R. T., Kimbrell, T. A., Corá-Locatelli, G., & Post, R. M. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00160-2 · Cited by 119
Clozapine-Associated Elevation in Serum Triglycerides
Gaulin, B. D., Markowitz, J. S., Caley, C. F., Nesbitt, L. A., & Dufresne, R. L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1270 · Cited by 119
Weight Gain in Adolescents Treated with Risperidone and Conventional Antipsychotics Over Six Months
Kelly, D. L., Conley, R. R., Love, R. C., HORN, D. S., & USHCHAK, C. M. (1998) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1998.8.151 · Cited by 111
Guille, C., Sachs, G. S., & Ghaemi, S. N. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0907 · Cited by 103
Sulpiride injections in the lateral hypothalamus induce feeding and drinking in rats
Parada, M. A., Hernandez, L., & Hoebel, B. G. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90120-7 · Cited by 102
Recent Advances in Basic Obesity Research
Yanovski, J. A., & Yanovski, S. Z. (1999) · JAMA · doi:10.1001/jama.282.16.1504 · Cited by 97
Antipsychotic agents and bipolar disorder.
Tohen, M. F., & Zarate, C. A. (1998) · PubMed · Cited by 95
Serum triglyceride levels in patients treated with clozapine
Ghaeli, P., & Dufresne, R. L. (1996) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/53.17.2079 · Cited by 85
Reduction of Food Intake by Manipulation of Central Serotonin Current Experimental Results
Garattini, S. K., Mennini, T., & SAMANIN, R. (1989) · The British Journal of Psychiatry · doi:10.1192/s0007125000291757 · Cited by 83
Yohimbine Impairs P50 Auditory Sensory Gating in Normal Subjects
Adler, L. E., Hoffer, L., Nagamoto, H. T., Waldo, M. C., Kisley, M. A., & Giffith, J. M. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.28 · Cited by 79
Ketoacidosis as a side‐effect of clozapine: a case report
Kostakolu, A. E., Yazici, M. K., Erbas, T. A., & Guvener, N. D. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb10635.x · Cited by 78
Uvnäs-Moberg, K., Ahlénius, S., Alster, P., & Hillegaart, V. (2008) · Neuroendocrinology · doi:10.1159/000126970 · Cited by 74
Olanzapine-Induced Elevation of Plasma Triglyceride Levels
Sheitman, B., BIRD, P. M., Binz, W., AKINLI, L., & SANCHEZ, C. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1471-a · Cited by 69
The relationship between blood prolactin levels and risk of breast cancer in premenopausal women
Wang, D. Y., Stavola, B. L. D., Bulbrook, R. D., Allen, D. S., Kwa, H. G., Verstraeten, A. A., Moore, J. W., Fentiman, I. S., Chaudary, M. A., Hayward, J. L., et al. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90098-8 · Cited by 66
Zervanos, N. J. (1998) · The Journal of the American Board of Family Medicine · doi:10.3122/15572625-11-2-174 · Cited by 64
Too many chronic mentally disabled patients are too fat
Gopalaswamy, A. K., & Morgan, R. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb02603.x · Cited by 62
Goodall, E., Oxtoby, C., Richards, R. P., Watkinson, G., Brown, D., & Silversonte, T. (1988) · The British Journal of Psychiatry · doi:10.1192/bjp.153.2.208 · Cited by 61
Nonpharmacologic and pharmacologic management of weight gain.
Greenberg, I., Chan, S., & Blackburn, G. L. (1999) · PubMed · Cited by 48
Weight reduction in schizophrenics by molindone
Gárdos, G., & Cole, J. O. (1977) · American Journal of Psychiatry · doi:10.1176/ajp.134.3.302 · Cited by 40
Lactic Acidosis and Fatal Myocardial Failure Due to Clozapine
Koren, W., Kreis, Y., Duchowiczny, K., Prince, T., Sancovici, S., Sidi, Y., & Gur, H. G. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703100206 · Cited by 40
Yamada, J., Sugimoto, Y., Yoshikawa, T., Kimura, I., & Horisaka, K. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02010-g · Cited by 39
Commercial Weight Loss Products and Programs: What Consumers Stand To Gain and Lose
Cleland, R. L., Graybill, D. C., Hubbard, V. S., Khan, L. K., Stern, J. S., Wadden, T. A., Weinsier, R. L., Yanovski, S. Z., Gross, W. C., & Daynard, M. (2001) · Critical Reviews in Food Science and Nutrition · doi:10.1080/20014091091733 · Cited by 34
Systemic sulpiride increases dopamine metabolites in the lateral hypothalamus
Baptista, T., Hernandez, L., & Hoebel, B. G. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90325-c · Cited by 29
Baptista, T., Alvarez, L., Lacruz, A., Mendoza, S., & HernÁndez, L. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00096-7 · Cited by 29
Conventional versus novel antipsychotics: changing concepts and clinical implications.
Remington, G. J., & Chong, S. A. (1999) · PubMed · Cited by 28
Psychotic mania associated with fenfluramine and phentermine use
Raison, C. L., & Klein, H. M. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.5.711a · Cited by 27
Aulakh, C. S., Hill, J., Yoney, H. T., & Murphy, D. L. (1992) · Psychopharmacology · doi:10.1007/bf02247721 · Cited by 27
Cabrera, R., Mayor, P., Fernández‐Ruíz, J., & Calle, C. (1988) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(88)90151-7 · Cited by 24
Psychotomimetic effects of anorectic drugs.
Khan, S. A., Spiegel, D. A., & Pc, J. (1987) · PubMed · Cited by 13
Dm, G., Mp, B., Steele, C. A., Bishop, G., & Guerrero-Figueroa, R. (1973) · PubMed · Cited by 9
(1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)80008-0 · Cited by 5
Cited by
Physical Health Monitoring of Patients With Schizophrenia
Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Casey, D. E., Davis, J. M., Kane, J. M., Lieberman, J. A., Schooler, N. R., Covell, N., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.8.1334 · Cited by 812
Kroeze, W. K., Hufeisen, S. J., Popadak, B. A., Renock, S. M., Steinberg, S., Ernsberger, P., Jayathilake, K., Meltzer, H. Y., & Roth, B. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300027 · Cited by 801
Correll, C. U., Leucht, S., & Kane, J. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.414 · Cited by 709
Inflamed moods: A review of the interactions between inflammation and mood disorders
Rosenblat, J. D., Cha, D. S., Mansur, R. B., & McIntyre, R. S. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.01.013 · Cited by 609
Self-citationAlmost All Antipsychotics Result in Weight Gain: A Meta-Analysis
Bak, M., Fransen, A., Janssen, J., van Os, J., & Drukker, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094112 · Cited by 490
“Subsequent metaanalyses confirmed the finding that most AP contributes to weight gain [20–26].”
Background
Metadata
- Authors
- McIntyre, R. S., McCann, S. M., & Kennedy, S. H.
- Venue
- The Canadian Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2001-04
- Volume
- 46
- Issue
- 3
- Pages
- 273-281
- ISSN
- 0706-7437 (ISSN-L)
- 1497-0015
- OpenAlex
- W1484975190
- Cited by
- 261
- References
- 72
- FWCI
- 18.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.